Gudrun Pohl
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 19
- Drug Transport and Resistance Mechanisms 9
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 3
-
- Erythropoietin and Anemia Treatment 5
- Iron Metabolism and Disorders 3
- Acute Myeloid Leukemia Research 3
- Co-authors
- Ie‐Ming Shih (1 shared paper)Robert Pirker (16 shared papers)Martin Filipits (15 shared papers)Thomas Stranzl (13 shared papers)Tian‐Li Wang (5 shared papers)Ie‐Ming Shih (4 shared papers)Robert J. Kurman (2 shared papers)Heinz Ludwig (5 shared papers)
- Journals
- Advances in experimental medicine and biology (2 papers)Blood (2 papers)Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Gudrun Pohl
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 98
- Oncology 518
- Reproductive Medicine 138
- Hematology 180
- Cancer Research 193
- Molecular Biology 615
Countries citing papers authored by Gudrun Pohl
This map shows the geographic impact of Gudrun Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Pohl more than expected).
Fields of papers citing papers by Gudrun Pohl
This network shows the impact of papers produced by Gudrun Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Pohl. The network helps show where Gudrun Pohl may publish in the future.
Co-authors
The 25 scholars most cited alongside Gudrun Pohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 157 | |
| 2 | 2004 | 154 | |
| 3 | 2005 | 126 | |
| 4 | 2008 | 112 | |
| 5 | 2005 | 107 | |
| 6 | 2005 | 94 | |
| 7 | 1998 | 92 | |
| 8 | Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. | 2002 | 77 |
| 9 | 2003 | 71 | |
| 10 | Anemia in multiple myeloma. | 2004 | 52 |
| 11 | 2000 | 50 | |
| 12 | 2003 | 48 | |
| 13 | 2003 | 43 | |
| 14 | Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. | 1999 | 39 |
| 15 | 2003 | 31 | |
| 16 | 1999 | 27 | |
| 17 | Expression of the multidrug resistance protein (MRP1) in breast cancer. | 2000 | 27 |
| 18 | Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma. | 2003 | 26 |
| 19 | 2005 | 20 | |
| 20 | Expression of the lung resistance protein (LRP) in primary breast cancer. | 2000 | 20 |
About Gudrun Pohl
Gudrun Pohl is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Erythropoietin and Anemia Treatment (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Iron Metabolism and Disorders (3 papers), Cancer-related Molecular Pathways (3 papers), PARP inhibition in cancer therapy (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Oncology (518 citations), Reproductive Medicine (138 citations), Hematology (180 citations), Cancer Research (193 citations) and Molecular Biology (615 citations). Gudrun Pohl has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Ie‐Ming Shih, Robert Pirker, Martin Filipits, Thomas Stranzl, Tian‐Li Wang, Ie‐Ming Shih, Robert J. Kurman, Heinz Ludwig, Margaretha Rudas and R. Jakesz. Their work appears in journals such as Advances in experimental medicine and biology, Blood, Cancer Research, Journal of Clinical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.